HHBT — HH Biotechnology Holdings Co Balance Sheet
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.00m
 - -$3.26m
 - $7.99m
 
Annual balance sheet for HH Biotechnology Holdings Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st  | 2012 December 31st  | 2013 December 31st  | 2014 December 31st  | 2015 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 6.29 | 5.93 | 7.12 | 8.8 | 9.82 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.246 | 0.255 | 0.329 | 4.68 | 0.911 | 
| Total Other Current Assets | |||||
| Total Current Assets | 6.54 | 6.18 | 7.46 | 13.5 | 10.7 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 49.7 | 46.9 | 45 | 40.5 | 35.7 | 
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 61.4 | 59.4 | 59.6 | 54 | 46.5 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 34.2 | 34.3 | 35.5 | 34.8 | 18.1 | 
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 34.2 | 34.3 | 35.5 | 34.8 | 18.2 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 27.2 | 25.1 | 24 | 19.1 | 28.2 | 
| Total Liabilities & Shareholders' Equity | 61.4 | 59.4 | 59.6 | 54 | 46.5 | 
| Total Common Shares Outstanding |